4-methylsulfanyl-6-phenyl-[1,3,5]-triazin-2-ylamine | 14945-93-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 4-methylsulfanyl-6-phenyl-[1,3,5]-triazin-2-ylamine
• 英文别名: 4-amino-2-methylthio-6-phenyl-1,3,5-triazine；4-methylsulfanyl-6-phenyl-[1,3,5]triazin-2-ylamine；4-Amino-6-methylmercapto-2-phenyl-1,3,5-triazin；4-(Methylsulfanyl)-6-phenyl-1,3,5-triazin-2-amine；4-methylsulfanyl-6-phenyl-1,3,5-triazin-2-amine
• CAS: 14945-93-8
• 化学式: C₁₀H₁₀N₄S
• mdl: MFCD18324668
• 分子量: 218.282
• InChiKey: WXNISKFTJGYTJO-UHFFFAOYSA-N

物化性质

• 熔点：
  174-176 °C
• 沸点：
  478.6±28.0 °C(Predicted)
• 密度：
  1.34±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  90
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N-Benzoyl-dithiocarbaminsaeure-methylester 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 苯 为溶剂， 反应 6.0h， 生成 4-methylsulfanyl-6-phenyl-[1,3,5]-triazin-2-ylamine
  参考文献：
  名称：

  Augustin, M.; Richter, M.; Salas, S., Journal fur praktische Chemie (Leipzig 1954), 1980, vol. 322, # 1, p. 55 - 68

  摘要：

  DOI：

文献信息

• Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone
  作者：Paul A. Brough、Xavier Barril、Jenifer Borgognoni、Patrick Chene、Nicholas G. M. Davies、Ben Davis、Martin J. Drysdale、Brian Dymock、Suzanne A. Eccles、Carlos Garcia-Echeverria、Christophe Fromont、Angela Hayes、Roderick E. Hubbard、Allan M. Jordan、Michael Rugaard Jensen、Andrew Massey、Angela Merrett、Antony Padfield、Rachel Parsons、Thomas Radimerski、Florence I. Raynaud、Alan Robertson、Stephen D. Roughley、Joseph Schoepfer、Heather Simmonite、Swee Y. Sharp、Allan Surgenor、Melanie Valenti、Steven Walls、Paul Webb、Mike Wood、Paul Workman、Lisa Wright

  DOI：10.1021/jm900357y

  日期：2009.8.13

  Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural

  Hsp90分子伴侣的抑制剂作为治疗癌症的潜在分子治疗剂已显示出可观的前景。在这里，我们描述了新型的2-aminothieno [2,3- d ]嘧啶ATP竞争性Hsp90抑制剂，该抑制剂是通过结合基于片段和计算机模拟筛选产生的独特的低亲和性命中的结构元素以及来自X-的结构信息而设计的射线蛋白质晶体学。该系列的示例具有很高的亲和力（IC 50在荧光极化（FP）竞争性结合试验中测得Hsp90为50-100 nM），并且在人类癌细胞系中具有活性，它们抑制细胞增殖并表现出致癌蛋白消耗和Hsp72随之升高的特征。当在人BT474人乳腺癌异种移植模型中口服施用时，几个实例（34a，34d和34i）以良好耐受的剂量引起肿瘤生长消退。
• ABCA-1 elevating compounds
  申请人：——

  公开号：US20020128266A1

  公开（公告）日：2002-09-12

  The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.

  本发明提供了一些化合物，可以提高ABCA-1基因的细胞表达，促进细胞中的胆固醇外流并增加哺乳动物（特别是人类）血浆中的高密度脂蛋白水平。这些化合物可用于治疗冠状动脉疾病。
• HSP90 Inhibitor
  申请人：Tsukuda Takuo

  公开号：US20090247524A1

  公开（公告）日：2009-10-01

  Compounds represented by formula (1) shown below, pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising such compounds are provided.

  提供了由下式（1）表示的化合物、药学上可接受的盐以及包含这些化合物的制药组合物。
• Solution- and Solid-Phase Synthesis of Combinatorial Libraries of Trisubstituted 1,3,5-Triazines
  作者：Thierry Masquelin、Nathalie Meunier、Fernand Gerber、Gérard Rossé

  DOI：10.3987/com-98-8231

  日期：——

  A general synthesis of trisusbstituted 1,3,5-triazines of types (4) and (5) by condensation of amidines (2) and thiouronium salts (3) with dimethyl cyanoiminodithiocarbonate (1) was first established in solution (Scheme 1). Further investigations were directed toward a multidirectional cleavage procedure of the 2-alkylsulfinyl intermediates with different nucleophiles to form highly substituted 1,3,5-triazines of type (8) and (9). This methodology was successfully transferred onto solid support taking advantages of a sulfur-based safety catch linkage, using the polymer-bound thiouronium salt (11) (Scheme 3). In addition, other compounds libraries were chemoselectively generated on solid support in good to excellent yields combining both solution- and solid-phase synthesis, starting from a resin-bound thiol (15) and cyanuric chloride (16) (Scheme 4).
• HSP90 INHIBITOR
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：EP2036895B1

  公开（公告）日：2013-01-16